Follow Bruker's experts as they discuss the SCRUM approach to software development in the scientific industry.

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

Baxter International Inc. BAX is scheduled to release first-quarter 2025 results on May 1, before the opening bell. In the ...

About Xeris Biopharma Holdings Inc. Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company ...

Helix BioPharma, a clinical-stage biopharmaceutical company, commits to innovating with purpose in this challenging landscape ...

In the Acceptance Letter, NYSE American granted the Company until August 3, 2026 (the "Plan Period”) to regain compliance with the continued listing standards. During the Plan Period, the Company will ...

Quantum BioPharma (NASDAQ: QNTM) has appointed Kevin Malone as an advisor to its Board of Directors. A seasoned financial advisor with over 40 years ...